Getting on Target for Alzheimer’s

A new genomic barcode tracker could help spot the rare immune cells that are most effective against cancer

Sitting Down With… Mike Clayman, CEO of Flexion Therapeutics, Inc., Burlington, Massachusetts, USA.

RNA Inhibitors - an exciting avenue for drug development? We collate the findings from the Innovation that Matters series, hosted by WuXi Xpress...

Sitting Down with Michael Tanner, Research Fellow in the School of Engineering and Physical Sciences at Heriot Watt University, Edinburgh, UK.

Researchers fine-tune 3D printing technology to create better biomimetic corneas – and predict a “breakthrough” in global transplantation practice.

A new study uses machine learning to perform meta-analysis of eight metagenomic studies linking gut microbial signatures with colorectal cancer.

Could modulation of fibroblast growth factor 21 translate into a new treatment for non-alcoholic fatty liver disease?

To truly understand the intricacies of pathogenic bacteria, we need to combine “pure” and translational research.

Combining metabolomics and DNA sequencing could be the key to discovering new inborn errors of metabolism in children.

We sit down with digital pathology advocate David Wilbur to discuss how the advancement of digital interfaces could lead to widespread adoption.